Director Shareholding

GlaxoSmithKline PLC 28 April 2004 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 26 April 2004 The Administrators of the SmithKline Beecham Employee Benefit Trust ("the Trust") notified the Company on 28 April 2004 that following reinvestment of the cash dividend paid to the shareholders on 15 April 2004 1,760 Ordinary Shares in the Company had been purchased for participants in the SmithKline Beecham Bonus Investment Plan at a price of £11.6575. The Trust also notified the Company on 28 April 2004 that following reinvestment of the cash dividend paid to shareholders on 15 April 2004, 7,227 Ordinary Shares in the Company had been purchased for participants in the GlaxoSmithKline Annual Investment Plan at a price of £11.66. The Trust also notified the Company on 28 April that 5,647 Ordinary Shares had been transferred to a participant of the Annual Investment Plan. The Trust is a discretionary fund of which all non US employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. One of the Company's directors, John Coombe is therefore interested in the shares held in the fund from time to time in the same way as other non US employees or former employees of GlaxoSmithKline plc and its subsidiaries. S M Bicknell Company Secretary 28 April 2004 This information is provided by RNS The company news service from the London Stock Exchange JTBBI

Companies

GSK (GSK)
UK 100